ZOSANO PHARMA
Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.
ZOSANO PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2006-10-01
Address:
Fremont, California, United States
Country:
United States
Website Url:
http://www.zosanopharma.com
Total Employee:
11+
Status:
Closed
Contact:
(510) 745-1200
Total Funding:
271.92 M USD
Technology used in webpage:
Google Maps IPv6 Akamai Hosted ATT
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Kojin Therapeutics
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Board_member
Board_member
2015-01-01
Board_member
Board_member
Board_member
2013-01-01
Current Employees Featured
Peter Daddona Exec VP, CSO @ Zosano Pharma
Exec VP, CSO
Chris Kruegar Chief Business Officer @ Zosano Pharma
Chief Business Officer
Founder
Stock Details
Investors List
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Zosano Pharma
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Zosano Pharma
Nomura International
Nomura International investment in Debt Financing - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Debt Financing - Zosano Pharma
BioMed Ventures
BioMed Ventures investment in Debt Financing - Zosano Pharma
ProQuest Investments
ProQuest Investments investment in Series B - Zosano Pharma
Phase4 Ventures
Phase4 Ventures investment in Series B - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Series B - Zosano Pharma
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Zosano Pharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Zosano Pharma
Official Site Inspections
http://www.zosanopharma.com
- Host name: ewhserver1302.edgewebhosting.net
- IP address: 69.63.140.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zosano Pharma"
Zosano Pharma Corporation - AnnualReports.com
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved …See details»
Zosano goes bankrupt after FDA rejects drug delivery patch
Jun 7, 2022 Zosano Pharma has run out of road. After working to find a strategic alternative in the wake of the FDA’s refusal to review its submission, the transdermal drug delivery specialist …See details»
Zosano Pharma - Org Chart, Teams, Culture & Jobs - The Org
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but …See details»
Zosano Pharma - LinkedIn
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the …See details»
Bankrupt Zosano Sells Its Drug Delivery Tech That …
Oct 12, 2022 Emergex Vaccines Holding Limited acquired the assets of Zosano Pharma Corporation. The sale was part of the customary proceedings after Zosano filed for bankruptcy in June. The assets acquired ...See details»
Zosano Pharma Company Profile - Craft
Aug 2, 2022 Zosano Pharma is a private pharmaceutical company focused on creating better products with their innovative drug delivery technology. Their lead program, parathyroid …See details»
Zosano Pharma - Contacts, Employees, Board Members
Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.See details»
Zosano Pharma CEO, Founder, Key Executive Team, Board of …
United Biomedical is a biopharmaceutical organization that develops diagnostics and immunotherapeutics for health conditions.See details»
Bankrupt Zosano sells intradermal delivery tech to …
Oct 18, 2022 The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has stepped in to provide a new ...See details»
Zosano Pharma | ZSAN Stock Price, Company Overview & News
Zosano Pharma. ZSAN. More on Forbes. 1 minute ago. Fed’s Favored Inflation Metric Ticked Up To 6-Month High In October. The core PCE inflation measure is half of its 2022 peak, but it’s …See details»
Zosano Pharma Provides Corporate Update - Yahoo Finance
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate …See details»
Zosano Pharma Announces Reverse Stock Split Effective Today
Apr 11, 2022 ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma …See details»
Zosano Pharma Provides Corporate Update - GlobeNewswire
Apr 29, 2022 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with …See details»
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021
FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial …See details»
Zosano Pharma Announces Partnership Agreement with …
Aug 6, 2020 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established …See details»
Zosano Pharma Announces Pricing of $15.4 Million Public Offering …
Feb 9, 2022 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established …See details»
Zosano Pharma Announces the Successful Formulation of a
Nov 17, 2021 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with …See details»
Zosano: From Phase 3 To Approval Of A Best-In-Class Migraine …
May 22, 2019 Zosano Pharma Corporation (NASDAQ: ZSAN) announced today it has received notification that the US Patent Application (US 15/438,455) was published by the US Patent …See details»
Zosano Pharma Announces the Successful Formulation of a COVID …
Nov 17, 2021 Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with …See details»